All In MedTech

Company

Abbvie

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

ABBV

NYSE · AbbVie Inc.

Public float

$325.1B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$61.2B

Fiscal year ending Dec 31, 2025

Net income

$4.23B

Fiscal year ending Dec 31, 2025

R&D spending

$9.10B

Fiscal year ending Dec 31, 2025

Cash

$10.8B

As of Sep 30, 2026

Long-term debt

$72.2B

As of Sep 30, 2026

Shares outstanding

1767.6M

As of Oct 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2025––$3.99B–
2024––$17.0B–
2022––$2.00B–
2021––$1.00B–

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Apr 25, 2016Equity

Issued in a merger or acquisition; not counted as money raised

$3.80B$3.80B39Rule 506(b)Form D ↗May 9, 2016

Company details

From the company's latest Form D.

Legal name
AbbVie Inc.
Headquarters
North Chicago, Illinois
Incorporated
Delaware in 2012
Entity type
Corporation
Revenue range
Over $100,000,000
Industry filed under
Pharmaceuticals

Executives, directors and promoters

As listed on the latest Form D.

    17 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Abbvie we have 1 shareholder with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    1 more FDA decisions with a free account

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    32 more trials with a free account

    Reports received

    615

    Received Nov 1, 2025 to Nov 20, 2026

    Malfunction reports

    59

    9.6% of reports

    Injury reports

    550

    89% of reports

    Death reports

    6

    1.0% of reports

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor
    • Malfunction
    • Injury
    • Death
    • Other
    View as table
    MonthMalfunctionInjuryDeathOther
    Dec 2309920
    Jan 2405710
    Feb 2406410
    Mar 2406910
    Apr 2416900
    May 2406310
    Jun 2407700
    Jul 2405600
    Aug 2404010
    Sep 2404600
    Oct 2405800
    Nov 2404800
    Dec 2405410
    Jan 2504520
    Feb 2505300
    Mar 2506100
    Apr 2504700
    May 2514710
    Jun 2504300
    Jul 2504510
    Aug 2504820
    Sep 2504200
    Oct 2504500
    Nov 2504710
    Dec 2525800
    Jan 2603400
    Feb 2613110
    Mar 2603110
    Apr 26398110
    May 26125200
    Jun 2654900
    Jul 2604510
    Aug 2604100
    Sep 2604000
    Oct 2604110
    Nov 260000

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    4 more in this ranking with a free account

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    7 more in this ranking with a free account

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    1 more recall records with a free account

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.